Literature DB >> 33454383

Dual 3D printing for vascularized bone tissue regeneration.

Sung Yun Hann1, Haitao Cui2, Timothy Esworthy3, Xuan Zhou4, Se-Jun Lee5, Michael W Plesniak6, Lijie Grace Zhang7.   

Abstract

The development of sufficient vascular networks is crucial for the successful fabrication of tissue constructs for regenerative medicine, as vascularization is essential to perform the metabolic functions of tissues, such as nutrient transportation and waste removal. In recent years, efforts to 3D print vascularized bone have gained substantial attention, as bone disorders and defects have a marked impact on the older generations of society. However, conventional and previous 3D printed bone studies have been plagued by the difficulty in obtaining the nanoscale geometrical precision necessary to recapitulate the distinct characteristics of natural bone. Additionally, the process of developing truly biomimetic vascularized bone tissue has been historically complex. In this study, a biomimetic nano-bone tissue construct with a perfusable, endothelialized vessel channel was developed using a combination of simple stereolithography (SLA) and fused deposition modeling (FDM) 3D printing systems. The perfusable vessel channel was created within the SLA printed bone scaffold using an FDM printed polyvinyl alcohol (PVA) sacrificial template. Within the fabricated constructs, bone tissue was formed through the osteogenic differentiation of human bone marrow mesenchymal stem cells (hMSCs), and distinct capillaries sprouted through the angiogenesis of the endothelialized vessel channel after human umbilical vein endothelial cells (HUVECs) had been perfused throughout. Furthermore, the fabricated constructs were evaluated in physiologically relevant culture conditions to predict tissue development after implantation in the human body. The experimental results revealed that the custom-designed bioreactor with an hMSC-HUVEC co-culture system enhanced the formation of vascular networks and the osteogenic maturation of the constructs for up to 20 days of observation.
Copyright © 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D printing; Biofabrication; Osteogenesis; Tissue regeneration; Vascular network

Mesh:

Year:  2021        PMID: 33454383     DOI: 10.1016/j.actbio.2021.01.012

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  6 in total

1.  The potential mechanism of Fructus Ligustri Lucidi promoting osteogenetic differentiation of bone marrow mesenchymal stem cells based on network pharmacology, molecular docking and experimental identification.

Authors:  Yuanhang Kong; Xinnan Ma; Xin Zhang; Leilei Wu; Dechun Chen; Bo Su; Daqian Liu; Xintao Wang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 2.  3D Printing: Applications in Tissue Engineering, Medical Devices, and Drug Delivery.

Authors:  B G Pavan Kalyan; Lalit Kumar
Journal:  AAPS PharmSciTech       Date:  2022-03-17       Impact factor: 4.026

3.  The Osteocyte Stimulated by Wnt Agonist SKL2001 Is a Safe Osteogenic Niche Improving Bioactivities in a Polycaprolactone and Cell Integrated 3D Module.

Authors:  Yangxi Liu; Xiaojie Ruan; Jun Li; Bo Wang; Jie Chen; Xiaofang Wang; Pengtao Wang; Xiaolin Tu
Journal:  Cells       Date:  2022-02-28       Impact factor: 6.600

4.  Convex and Concave Model 3D Printing for Designing Right-side Bronchial Blocker for Infants.

Authors:  Xiaomin Duan; Wei Wang; Wenping Ma; Zhenhui Mao; Fangliang Xing; Xin Zhao
Journal:  Int J Bioprint       Date:  2022-04-29

Review 5.  In Vitro Strategies to Vascularize 3D Physiologically Relevant Models.

Authors:  Alessandra Dellaquila; Chau Le Bao; Didier Letourneur; Teresa Simon-Yarza
Journal:  Adv Sci (Weinh)       Date:  2021-08-05       Impact factor: 16.806

Review 6.  Perfused Platforms to Mimic Bone Microenvironment at the Macro/Milli/Microscale: Pros and Cons.

Authors:  Maria Veronica Lipreri; Nicola Baldini; Gabriela Graziani; Sofia Avnet
Journal:  Front Cell Dev Biol       Date:  2022-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.